HSIC Henry Schein, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 4, 2026HSIC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
HSIC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| Feb. 8, 2019 | 51-for-40 | Forward |
| Sept. 15, 2017 | 2-for-1 | Forward |
| March 1, 2005 | 2-for-1 | Forward |
About Henry Schein, Inc. - Common Stock Company overview from Wikipedia
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | HSIC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 24.75Y avg ≈21.5 | ≈21.5 | 22.9 | Overvalued | |
| P/S (TTM) | 0.75Y avg ≈0.8 | ≈0.8 | 0.5 | Overvalued | |
| P/B (MRQ) | 3.05Y avg ≈2.8 | ≈2.8 | · | · | |
| EV / EBITDA | 10.75Y avg ≈10.4 | ≈10.4 | · | · | |
| Price / FCF (TTM) | 16.75Y avg ≈18.5 | ≈18.5 | · | · | |
| Price / Cash Flow (TTM) | 13.65Y avg ≈14.8 | ≈14.8 | 14.0 | Fair value | |
| EV / Revenue | 0.85Y avg ≈0.8 | ≈0.8 | · | · | |
| EV / FCF | 18.05Y avg ≈18.9 | ≈18.9 | · | · | |
| Price / Tangible Book (MRQ) | 4.3 | · | · | · | |
| PEG Ratio | ≈8.2 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | HSIC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 31.3%5Y avg ≈30.8% | ≈30.8% | 4.3% | Top tier | |
| Operating Margin (TTM) | 5.0%5Y avg ≈5.5% | ≈5.5% | 1.1% | Top tier | |
| EBITDA Margin (TTM) | 7.4%5Y avg ≈7.5% | ≈7.5% | 1.3% | Top tier | |
| Pretax Margin (TTM) | 4.1%5Y avg ≈5.0% | ≈5.0% | 1.0% | Top tier | |
| Net Profit Margin (TTM) | 3.0%5Y avg ≈3.8% | ≈3.8% | 0.63% | Top tier | |
| ROA (TTM) | 3.6%5Y avg ≈5.2% | ≈5.2% | 3.1% | Top tier | |
| ROE (TTM) | 12.2%5Y avg ≈13.8% | ≈13.8% | -4.6% | Top tier | |
| ROIC | 12.4%5Y avg ≈14.2% | ≈14.2% | 12.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | HSIC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.35Y avg ≈0.1 | ≈0.1 | 0.3 | In line | |
| Current Ratio (MRQ) | 1.35Y avg ≈1.6 | ≈1.6 | 0.9 | Strong liquidity | |
| Quick Ratio | 0.65Y avg ≈0.7 | ≈0.7 | 0.5 | Strong liquidity | |
| Interest Coverage | 4.45Y avg ≈12.8 | ≈12.8 | 5.9 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | HSIC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 4.0%5Y avg ≈5.8% | ≈5.8% | · | · | |
| Revenue CAGR 3Y | 1.4%5Y avg ≈3.0% | ≈3.0% | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | |
| EPS YoY | 7.2%5Y avg ≈6.0% | ≈6.0% | · | · | |
| Net Income YoY | 2.1%5Y avg ≈2.9% | ≈2.9% | · | · | |
| EPS CAGR 3Y | -5.8%5Y avg ≈-4.6% | ≈-4.6% | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | |
| Net Income CAGR 3Y | -9.6%5Y avg ≈-7.8% | ≈-7.8% | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | HSIC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.25Y avg ≈1.3 | ≈1.3 | 4.5 | Weak | |
| Inventory Turnover | 4.85Y avg ≈4.8 | ≈4.8 | 15.7 | Weak | |
| Receivables Turnover | 8.45Y avg ≈8.2 | ≈8.2 | 13.1 | Weak | |
| Revenue / Employee | ≈$527.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $1.27 | $1.26 | 0.67% |
| March 31, 2026 | May 12, 2026 | $1.32 | $1.24 | 6.3% |
| Dec. 31, 2025 | $1.34 | $1.33 | 1.1% | |
| Sept. 30, 2025 | $1.38 | $1.30 | 5.8% | |
| June 30, 2025 | $1.10 | $1.22 | -9.5% | |
| March 31, 2025 | $1.15 | $1.13 | 1.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.03 | $27.33 | $28.28 | $26.15 | $24.97 | $23.50 | $20.91 | $19.56 | · | $35.18 | $35.00 | |
| Revenue / Share | $108.32 | $99.18 | $93.66 | $91.81 | $87.47 | $70.56 | $66.90 | $85.89 | · | $141.36 | $126.36 | |
| Cash Flow / Share | $5.85 | $6.64 | $3.80 | $4.37 | $5.00 | $4.18 | $4.38 | $4.45 | · | $7.52 | $6.98 | |
| Cash / Share | $1.35 | $0.98 | $1.32 | $0.89 | $0.86 | · | · | $0.53 | · | $0.79 | $0.87 | |
| EPS (TTM) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | · | $3.10 | $2.85 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | · | 120,199,552 | 121,927,867 | 123,776,073 | · | 126,124,715 | 127,784,380 | 128,720,661 | · | 130,388,353 | 131,365,789 | · | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | · | 121,036,247 | 122,636,948 | 124,848,221 | · | 127,054,934 | 128,646,506 | 129,769,580 | · | 131,442,135 | 133,039,886 | · | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.21 | $28.54 | · | $28.35 | $28.26 | $27.08 | · | $27.99 | $27.64 | $28.02 | · | $28.10 | · | · | $26.70 | |
| Revenue / Share | $30.23 | $29.02 | · | $27.59 | $26.42 | $25.37 | · | $24.98 | $24.38 | $24.44 | · | $24.06 | $23.00 | · | $22.37 | |
| Cash Flow / Share | · | $-0.84 | · | · | · | $0.30 | · | · | · | $1.52 | · | · | $0.20 | · | · | |
| Cash / Share | $1.40 | $1.21 | · | $1.15 | $1.19 | $1.04 | · | $1.01 | $1.09 | $1.24 | · | $1.28 | · | · | · | |
| EPS (TTM) | $3.43 | $3.31 | · | $3.17 | $3.11 | $3.21 | · | $2.44 | $2.71 | $2.97 | · | $3.38 | $3.52 | · | $4.59 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.60B | $13.38B | · | $12.94B | $12.77B | $12.67B | · | $12.50B | $12.49B | $12.45B | · | $12.69B | $12.53B | · | $12.61B | |
| Net Income TTM | $403M | $395M | · | $391M | $389M | $407M | · | $314M | $352M | $388M | · | $445M | $478M | · | $638M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 24.8 | 21.8 | · | 20.8 | 23.6 | 21.4 | · | 30.0 | 23.7 | 25.4 | · | 22.0 | 23.2 | · | 14.7 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.7 | · | · | · | |
| Earnings Yield | 4.0% | 4.6% | · | 4.8% | 4.2% | 4.7% | · | 3.3% | 4.2% | 3.9% | · | 4.5% | 4.3% | · | 6.8% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Gross Margin % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| Operating Margin % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| Net Income | $398M | $390M | $416M | $538M | $631M |
| Diluted EPS | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
| Metric | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
| Metric | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M |
Institutional owners (13F) 600 filers · $11.2B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 64 (-16 vs prior Q) | 60 (+14 vs prior Q) | 173 (-3 vs prior Q) | 220 (+25 vs prior Q) | +9.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1,307,257,713 | 15,652,032 | 11.68% | Shares |
| VANGUARD GROUP INC | $875,836,080 | 11,588,199 | 7.82% | Shares |
| FMR LLC | $630,901,802 | 7,553,901 | 5.64% | Shares |
| BlackRock, Inc. | $586,699,894 | 7,024,663 | 5.24% | Shares |
| Artisan Partners Limited Partnership | $540,162,844 | 6,467,467 | 4.82% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $530,073,795 | 6,346,669 | 4.73% | Shares |
| JPMORGAN CHASE & CO | $366,432,667 | 4,342,929 | 3.27% | Shares |
| STATE STREET CORP | $359,576,652 | 4,305,276 | 3.21% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345,225,076 | 4,133,442 | 3.08% | Shares |
| AMERICAN CENTURY COMPANIES INC | $288,743,396 | 3,457,175 | 2.58% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $283,495,786 | 3,394,242 | 2.53% | Shares |
| Southpoint Capital Advisors LP | $275,616,000 | 3,300,000 | 2.46% | Shares |
| Invesco Ltd. | $263,107,794 | 3,150,237 | 2.35% | Shares |
| CITADEL ADVISORS LLC | $243,970,523 | 2,921,103 | 2.18% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $227,537,373 | 2,729,030 | 2.03% | Shares |
| Palestra Capital Management LLC | $204,347,632 | 2,446,691 | 1.83% | Shares |
| BANK OF MONTREAL /CAN/ | $176,687,394 | 2,115,510 | 1.58% | Shares |
| MORGAN STANLEY | $175,460,572 | 2,100,819 | 1.57% | Shares |
| FIDUCIARY MANAGEMENT INC /WI/ | $151,785,323 | 1,817,353 | 1.36% | Shares |
| Burgundy Asset Management Ltd. | $151,049,204 | 2,170,871 | 1.35% | Shares |
| LYRICAL ASSET MANAGEMENT LP | $122,553,156 | 1,467,351 | 1.09% | Shares |
| UBS Group AG | $111,653,127 | 1,336,843 | 1.00% | Shares |
| Swedbank AB | $109,479,854 | 1,310,822 | 0.98% | Shares |
| M.D. Sass, LLC | $107,485,396 | 1,286,942 | 0.96% | Shares |
| SNYDER CAPITAL MANAGEMENT L P | $107,341,992 | 1,285,225 | 0.96% | Shares |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $107,262,144 | 1,272,537 | 0.96% | Shares |
| NORGES BANK | $103,383,729 | 1,237,832 | 0.92% | Shares |
| BANK OF AMERICA CORP /DE/ | $101,266,079 | 1,212,477 | 0.90% | Shares |
| GOLDMAN SACHS GROUP INC | $98,070,544 | 1,174,216 | 0.88% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86,593,118 | 1,036,795 | 0.77% | Shares |
| NORTHERN TRUST CORP | $80,548,694 | 964,424 | 0.72% | Shares |
| NOMURA HOLDINGS INC | $77,065,658 | 922,721 | 0.69% | Shares |
| PZENA INVESTMENT MANAGEMENT LLC | $71,888,420 | 860,733 | 0.64% | Shares |
| DME Capital Management, LP | $60,013,296 | 718,550 | 0.54% | Shares |
| Ananym Capital Management, LP | $57,978,164 | 694,183 | 0.52% | Shares |
| Ulysses Management LLC | $55,570,700 | 665,358 | 0.50% | Shares |
| STALEY CAPITAL ADVISERS INC | $55,252,489 | 661,548 | 0.49% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $45,489,502 | 544,654 | 0.41% | Shares |
| RAYMOND JAMES FINANCIAL INC | $42,948,907 | 514,235 | 0.38% | Shares |
| Bank of New York Mellon Corp | $42,261,071 | 505,999 | 0.38% | Shares |
| Nuveen, LLC | $38,262,099 | 458,119 | 0.34% | Shares |
| DEUTSCHE BANK AG\ | $36,574,075 | 437,908 | 0.33% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35,970,895 | 430,686 | 0.32% | Shares |
| Clarkston Capital Partners, LLC | $35,168,100 | 421,074 | 0.31% | Shares |
| LONE PEAK GLOBAL INVESTORS LLC | $33,404,158 | 399,954 | 0.30% | Shares |
| GAMCO INVESTORS, INC. ET AL | $30,537,668 | 365,633 | 0.27% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $27,342,332 | 370,995 | 0.24% | Shares |
| PRIVATE MANAGEMENT GROUP INC | $27,285,483 | 326,694 | 0.24% | Shares |
| FRANKLIN RESOURCES INC | $25,575,244 | 306,217 | 0.23% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $25,194,142 | 301,654 | 0.23% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 filings | March 10, 2026 | 16.40% | Amendment | · | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 filings | Aug. 8, 2025 | 13.00% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 52 insiders · 25 officers · 22 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | Sept. 8, 2026 D | 116,104 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | March 19, 2026 S | 86,182 | 0 | 1 | $-98,630 |
| Frederick M. Lowery | CEO | March 6, 2026 A | 95,156 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | March 19, 2025 S | 62,688 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | June 12, 2023 S | 68,690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | March 2, 2018 A | 62,902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | March 15, 2016 S | 31,000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | March 16, 2026 F | 88,930 | 0 | 0 | $0 |
| James P Breslawski | President | March 14, 2025 D | 200,227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | March 6, 2017 A | 9,654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | March 7, 2013 M | 48,716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | March 17, 2026 G | 112,208 | 0 | 0 | $0 |
| Christine Zayac Sheehy | SVP, Chief Human Res. Officer | March 16, 2026 F | 18,454 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | March 16, 2026 F | 98,372 | 0 | 2 | $-478,758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | March 14, 2025 D | 43,191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | Sept. 6, 2024 S | 71,833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | May 26, 2022 S | 95,616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | Nov. 30, 2018 S | 68,012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | Sept. 6, 2017 S | 17,841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | May 12, 2017 S | 22,943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | March 20, 2017 M | 23,088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | March 13, 2017 S | 14,277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | March 8, 2017 S | 16,589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | March 2, 2016 F | 25,144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | March 17, 2015 S | 12,343 | 0 | 0 | $0 |
| William K Daniel | Director | June 12, 2026 A | 7,641 | 1 | 0 | $691,900 |
| Scott Philip Serota | Director | March 6, 2026 A | 10,790 | 0 | 0 | $0 |
| Carole T Faig | Director | March 6, 2026 A | 8,025 | 0 | 0 | $0 |
| Anne H. Margulies | Director | March 6, 2026 A | 23,153 | 0 | 0 | $0 |
| Mohamad Ali | Director | March 6, 2026 A | 15,075 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | Director | March 6, 2026 A | 12,520 | 0 | 0 | $0 |
| Robert J. Hombach | Director | March 6, 2026 A | 5,421 | 0 | 0 | $0 |
| Bradley T Sheares | Director | March 6, 2026 A | 47,623 | 0 | 0 | $0 |
| Philip A Laskawy | Director | March 6, 2026 A | 24,538 | 0 | 1 | $-228,544 |
| Carol Raphael | Director | May 21, 2025 F | 33,538 | 0 | 0 | $0 |
| Steven Paladino | Director | March 4, 2024 A | 138,272 | 0 | 0 | $0 |
| Dianne E Rekow | Director | March 16, 2022 A | 18,526 | 0 | 0 | $0 |
| Barry J Alperin | Director | March 16, 2022 A | 52,473 | 0 | 0 | $0 |
| Paul Brons | Director | March 3, 2021 F | 16,854 | 0 | 0 | $0 |
| Shira Goodman | Director | March 3, 2021 A | 5,689 | 0 | 0 | $0 |
| Lawrence S Bacow | Director | March 6, 2018 F | 10,115 | 0 | 0 | $0 |
| Donald J Kabat | Director | March 6, 2018 F | 10,874 | 0 | 0 | $0 |
| Louis W Sullivan | Director | March 31, 2016 A | 14,096 | 0 | 0 | $0 |
| Norman S Matthews | Director | March 31, 2016 A | 12,890 | 0 | 0 | $0 |
| Karyn Mashima | Director | March 10, 2014 F | 19,269 | 0 | 0 | $0 |
| Irving Shafran | Director | Nov. 20, 2003 S | 750,000 | 0 | 0 | $0 |
| Stanley M Bergman | · | May 26, 2026 G | 253,279 | 0 | 5 | $-7,544,687 |
| Kurt P Kuehn | · | March 10, 2026 S | 15,420 | 0 | 1 | $-224,562 |
| Deborah Derby | · | March 6, 2026 A | 15,093 | 0 | 0 | $0 |
| Joseph L Herring | · | March 6, 2026 A | 30,325 | 0 | 0 | $0 |
| Margaret A Hamburg | · | May 20, 2009 M | 0 | 0 | 0 | $0 |
| Pamela Joseph | · | Nov. 16, 2004 S | 98,879 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 86 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1.59% | 163,520 SH | Oct. 2, 2026 | Daily |
| GURU · Global X Funds | 1.29% | 9,179 NS | July 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.87% | 106,077 NS | July 31, 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.65% | 126,921 SH | Oct. 2, 2026 | Daily |
| FBCV · FIDELITY COVINGTON TRUST | 0.36% | 7,509 NS | July 31, 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.33% | 18,150 NS | July 31, 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.33% | 12,855 NS | July 31, 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.28% | 54,697 SH | Oct. 2, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.23% | 17,140 NS | July 31, 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.22% | 364,767 NS | July 31, 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 2,218,557 SH | Oct. 2, 2026 | Daily |
| FSMD · FIDELITY COVINGTON TRUST | 0.20% | 57,583 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.19% | 343,006 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.18% | 58,607 SH | Sept. 11, 2026 | Daily |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.17% | 41,019 NS | July 31, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.17% | 1,416,056 SH | Aug. 19, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.15% | 24,666 NS | July 31, 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.15% | 3,879 NS | July 31, 2026 | N-PORT |
| IYH · iShares Trust | 0.14% | 57,526 SH | Sept. 11, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.14% | 20,654 NS | July 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.12% | 46,652 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.12% | 293,098 SH | Aug. 19, 2026 | Daily |
| SMMD · iShares Trust | 0.12% | 52,697 SH | Sept. 11, 2026 | Daily |
| IXJ · iShares Trust | 0.11% | 51,636 SH | Sept. 11, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.10% | 2,230,411 SH | Aug. 19, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.10% | 1,905 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 8,660 SH | Oct. 2, 2026 | Daily |
| VFMF · VANGUARD WELLINGTON FUND | 0.09% | 7,550 SH | Aug. 19, 2026 | Daily |
| IWS · iShares Trust | 0.08% | 146,411 SH | Sept. 10, 2026 | Daily |
| TILT · FlexShares Trust | 0.08% | 20,224 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.08% | 6,020 SH | Sept. 11, 2026 | Daily |
| VFVA · VANGUARD WELLINGTON FUND | 0.07% | 7,214 SH | Aug. 19, 2026 | Daily |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.07% | 77,119 SH | Oct. 2, 2026 | Daily |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 6,494 NS | July 31, 2026 | N-PORT |
| IWR · iShares Trust | 0.06% | 403,437 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.06% | 98,929 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.05% | 13,423 NS | July 31, 2026 | N-PORT |
| XOEF · iShares Trust | 0.05% | 125 SH | Sept. 11, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.05% | 270,764 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.05% | 2,999 NS | July 31, 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.04% | 5,048 SH | Oct. 2, 2026 | Daily |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.04% | 858 NS | July 31, 2026 | N-PORT |
| CATH · Global X Funds | 0.04% | 6,000 NS | July 31, 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.04% | 44,360 SH | Oct. 2, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.03% | 13,104 NS | July 31, 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.03% | 22,387 SH | Aug. 19, 2026 | Daily |
| IVE · iShares Trust | 0.03% | 160,669 SH | Sept. 11, 2026 | Daily |
| IUSV · iShares Trust | 0.03% | 83,684 SH | Sept. 11, 2026 | Daily |
| CHRI · Global X Funds | 0.03% | 24 NS | July 31, 2026 | N-PORT |
| DSI · iShares Trust | 0.02% | 14,799 SH | Sept. 10, 2026 | Daily |
| IWD · iShares Trust | 0.02% | 218,760 SH | Sept. 11, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 59,466 SH | Aug. 19, 2026 | Daily |
| EGLE · Global X Funds | 0.02% | 5 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.02% | 25,929 NS | July 31, 2026 | N-PORT |
| XYLG · Global X Funds | 0.02% | 132 NS | July 31, 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.02% | 3,116 SH | Oct. 2, 2026 | Daily |
| TOPC · iShares Trust | 0.02% | 59 SH | Sept. 10, 2026 | Daily |
| XCLR · Global X Funds | 0.01% | 6 NS | July 31, 2026 | N-PORT |
| XVV · iShares Trust | 0.01% | 1,104 SH | Sept. 11, 2026 | Daily |
| PTLC · Pacer Funds Trust | 0.01% | 5,070 NS | July 31, 2026 | N-PORT |
| IVV · iShares Trust | 0.01% | 1,220,662 SH | Sept. 11, 2026 | Daily |
| XYLD · Global X Funds | 0.01% | 4,788 NS | July 31, 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 576 SH | Oct. 2, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.01% | 30,222 NS | July 31, 2026 | N-PORT |
| IWB · iShares Trust | 0.01% | 68,043 SH | Sept. 11, 2026 | Daily |
| XRMI · Global X Funds | 0.01% | 70 NS | July 31, 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.01% | 365 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.01% | 27,083 SH | Sept. 9, 2026 | Daily |
| IYY · iShares Trust | 0.01% | 4,036 SH | Sept. 10, 2026 | Daily |
| QDPL · Pacer Funds Trust | 0.01% | 2,304 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.01% | 123,729 SH | Sept. 11, 2026 | Daily |
| PHDG · Invesco Actively Managed Exchange-T… | 0.01% | 77 SH | Oct. 2, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.01% | 674 NS | July 31, 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.01% | 2,513,394 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 3,089,160 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 81,658 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 16,261 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 8,309 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.01% | 22,281 SH | Aug. 19, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.01% | 7,569 NS | July 31, 2026 | N-PORT |
| XTR · Global X Funds | 0.01% | 4 NS | July 31, 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.00% | 99 NS | July 31, 2026 | N-PORT |
| ISCB · iShares Trust | · | 4,208 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 20,757 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 8,316 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 19,508 SH | Aug. 19, 2026 | Daily |
HSIC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
15 analysts · 2026-09-30Mean target $97.27 +14.6%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.